Daré Bioscience, Inc.
DARE
$1.85
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.03M | -57.10K | -17.70K | 25.90K | 9.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03M | -57.10K | -17.70K | 25.90K | 9.80K |
| Cost of Revenue | 2.59M | 2.29M | 2.29M | 2.29M | 3.35M |
| Gross Profit | -1.56M | -2.35M | -2.31M | -2.26M | -3.34M |
| SG&A Expenses | 8.76M | 9.18M | 8.72M | 8.79M | 9.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.58M | 17.41M | 18.46M | 22.04M | 23.46M |
| Operating Income | -13.55M | -17.47M | -18.48M | -22.01M | -23.45M |
| Income Before Tax | -13.40M | -17.46M | -18.60M | -1.68M | -4.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.40 | -17.46 | -18.60 | -1.68 | -4.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.40M | -17.46M | -18.60M | -1.68M | -4.05M |
| EBIT | -13.55M | -17.47M | -18.48M | -22.01M | -23.45M |
| EBITDA | -11.92M | -16.36M | -17.84M | -21.82M | -23.41M |
| EPS Basic | -1.33 | -1.92 | -2.19 | -0.20 | -0.51 |
| Normalized Basic EPS | -0.83 | -1.20 | -1.37 | -0.13 | -0.32 |
| EPS Diluted | -1.43 | -1.92 | -2.19 | -0.22 | -0.53 |
| Normalized Diluted EPS | -0.83 | -1.20 | -1.37 | -0.13 | -0.33 |
| Average Basic Shares Outstanding | 44.67M | 38.40M | 34.18M | 33.72M | 33.34M |
| Average Diluted Shares Outstanding | 44.67M | 38.40M | 34.18M | 33.79M | 33.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |